Sentinel Oncology will be participating in the following events


19th - 23rd October 2013

EORTC / NCI - Boston


7th - 9th November 2013

EORTC - Brussels   



Contact details

Sentinel Oncology Limited
23 Cambridge Science Park
Milton Road


Tel: +44(0)1223 437123
Fax: +44(0)1223 437125


General enquiries:

Investors & Partnering:

Welcome to Sentinel Oncology


Sentinel Oncology Limited is committed to the discovery of new and innovate treatments for cancer patients. We are passionate about advancing novel ideas for new cancer drugs from concept to candidate drug selection....more


Our R&D is focused on the development of targeted therapeutics for areas of unmet medical need in oncology....more




Latest news & press releases

May 2013

Sentinel Oncology achieves milestone in Horizon Discovery agreement

Cambridge, UK, 8th May 2013: Sentinel Oncology (Sentinel) today announced it has achieved a research milestone in its collaboration… read more

March 2013

Sentinel Oncology begin Discovery Collaboration with Professor Anthony Chalmers

Sentinel Oncology Limited (Sentinel) is pleased to announce the start of a collaboration with Professor Anthony Chalmers… read more

November 2012

Sentinel Oncology awarded Biomedical Catalyst funding to develop cancer drug

Sentinel Oncology is pleased to announce that it was recently awarded an Early Stage grant as part of the government-backed… read more